Results 81 to 90 of about 21,622 (232)
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment primarily for hematological malignancies. Infections, relapse, and graft versus host disease (GvHD) are some of the most common adverse events following HSCT. We aimed to evaluate whether the lymphocyte function of the stem cell graft was associated with these ...
Anna Söderström +8 more
wiley +1 more source
Changes in IPSS before and after surgery.
Figures are mean ± standard deviation, *P = .001.IPSS, International Prostate Symptom Score.
Yong-kuan Cao (483365) +5 more
core +1 more source
ABSTRACT The recently published ONKOPEDIA guideline on myelofibrosis, issued under the auspices of the German Society of Hematology and Oncology (DGHO), provides an updated, evidence‐based framework for the diagnosis and management of this rare, chronic myeloproliferative neoplasm.
Martin Griesshammer +8 more
wiley +1 more source
Conhecimento e gestão sustentável de uma IPSS
Orientação: João Pedro da Cruz Fernandes ThomazO conceito de sustentabilidade é hoje transversal a qualquer atividade organizacional, quer seja de caracter empresarial, quer seja do âmbito da economia social, no caso em análise, das IPSS.
Gonçalves, António Carvalho
core +1 more source
Introduction. Benign prostate hyperplasia (BPH) is an enlargement of the prostate due to abnormal proliferation or apoptosis failure of the epithelial or stroma tissues.Objective.
A. N. Hakim, S. Soetojo, P. Lestari
doaj +1 more source
The ‘Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease’ (PATROL) study
Background Inherited (germline) pathogenic and likely pathogenic variants (gPVs) in key genes associated with increased risk of prostate cancer (PCa) now warrant more attentive PCa screening per National Comprehensive Cancer Network (NCCN) guidelines—e.g., BRCA2, HOXB13, ATM, BRCA1, MSH2, MSH6, CHEK2 and TP53.
Heather H. Cheng +12 more
wiley +1 more source
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? [PDF]
In patients with myelodysplastic syndrome (MDS), higher revised International Prognostic Scoring System (IPSS-R) scores at transplant are associated with worse transplant outcome and, thus, lowering IPSS-R scores by therapeutic intervention before ...
Eikema D. J. +29 more
core +2 more sources
ABSTRACT Background Real‐world data on transfusion needs of patients with myelodysplastic syndromes (MDS), and the impacts of disease‐modifying therapies (DMTs) are sparse. In 2011, 5‐azacitidine became the first funded DMT for MDS and chronic myelomonocytic leukaemia (CMML) patients in Australia and national patient blood management (PBM) guidelines ...
Allison Mo +5 more
wiley +1 more source
Background International Prostate Symptom Score (IPSS) is a widely used as a standard, despite the fact that many patients find it time-consuming and confusing.
Bhusan Raj Timilsina +7 more
doaj +1 more source
Background: The complexity of International Prostate Symptom Score (IPSS) as an objective questionnaire for lower urinary tract symptoms might be overcome with alternative questionnaire such as the Visual Prostate Symptom Score (VPSS) which uses ...
I.B.O.W. Putra +4 more
doaj +1 more source

